Diagnosis: Morbilliform (exanthematous) drug eruption
A 34-year-old female presented with a generalized maculopapular eruption two weeks into sulfa therapy for a urinary tract infection. The eruption was pruritic, with involvement of the trunk and extremities, and resolved upon discontinuation of the offending agent, highlighting the importance of recognizing drug-induced cutaneous reactions.
A 34-year-old female presented with a generalized maculopapular eruption that developed two weeks after starting sulfa therapy for a urinary tract infection. The eruption was pruritic and involved the trunk and extremities, with no associated systemic symptoms such as fever or mucosal involvement upon examination.Distribution: Symmetric involvement of the trunk and extremities.Lesion morphology: Erythematous macules and papules coalescing into plaques.Associated symptoms: Mild pruritus without systemic manifestations.Examination findings: No vesicles, pustules, or desquamation noted.Resolution: Lesions resolved following discontinuation of sulfa medication.
The eruption began approximately two weeks after the initiation of sulfa therapy. The patient had no previous history of drug allergies and was otherwise healthy, with no significant past medical or family history. There were no recent changes in medications besides the sulfa drug. The patient's social history was notable for occasional use of over-the-counter medications, but no known allergies were reported.Onset: Eruption began two weeks after sulfa therapy initiation.Previous drug reactions: No history of adverse reactions to medications.Family history: No family history of drug allergies or skin disorders.Social history: No recent travel or exposure to new substances.Other medications: No other medications taken concurrently with sulfa.
Acute / First-Line ManagementImmediate discontinuation of the offending agent (sulfa medication).Consideration of oral antihistamines (e.g., diphenhydramine 25-50 mg every 6-8 hours as needed for pruritus).Topical corticosteroids (e.g., hydrocortisone 1% cream applied to affected areas twice daily) for symptomatic relief.Workup and Diagnostic ConfirmationClinical diagnosis based on history and physical examination findings.Patch testing may be considered in cases of uncertainty or if the patient has a history of similar eruptions.Laboratory tests (e.g., CBC, liver function tests) may be performed to rule out other causes if systemic symptoms develop.Long-Term ManagementPatient education regarding the importance of avoiding sulfa-containing medications in the future.Documentation of the allergic reaction in the patient's medical record.Follow-up visit to monitor for recurrence or new symptoms.
Viral exanthems: Common viral infections such as measles or rubella can present with similar maculopapular eruptions but are usually associated with systemic symptoms like fever.Fixed drug eruption: Characterized by well-defined plaques that recur at the same site upon re-exposure to the responsible medication, unlike the generalized distribution seen here.Urticaria: Presents as wheals and is often associated with pruritus, but lacks the maculopapular morphology and may be rapidly evolving.Scabies: Typically presents with intense pruritus and excoriated papules, often in intertriginous areas, rather than a generalized eruption.Contact dermatitis: Usually localized to areas of contact with an irritant or allergen; systemic involvement is rare.Systemic lupus erythematosus: Can cause drug-induced skin eruptions, but typically presents with additional systemic symptoms or specific skin findings such as a butterfly rash.Stevens-Johnson syndrome: A severe drug reaction with mucosal involvement and systemic symptoms, which is not present in this case.Acute generalized exanthematous pustulosis (AGEP): Characterized by the sudden onset of pustular eruptions, often following antibiotic exposure, and is associated with fever.
High-Yield PearlsDrug history: Always obtain a detailed medication history in patients with new-onset skin eruptions.Timing: The onset of drug eruptions typically occurs within 1-3 weeks of exposure, depending on the medication.Symptom resolution: Discontinuation of the offending drug usually leads to resolution of the skin findings within days to weeks.Documentation: Documenting drug allergies is crucial for preventing future adverse reactions.Patient education: Educate patients on recognizing signs of drug reactions and the importance of reporting them.Always consider drug eruptions in the differential of new skin lesions, especially in the context of recent medication changes.
Tags: drug eruption, morbilliform, sulfa